Exact Mass: 377.1990832
Exact Mass Matches: 377.1990832
Found 500 metabolites which its exact mass value is equals to given mass value 377.1990832,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Cryptopleurine
An organic heteropentacyclic compound that is (14aR)-11,12,13,14,14a,15-hexahydro-9H-dibenzo[f,h]pyrido[1,2-b]isoquinoline substituted at positions 2, 3 and 6 by methoxy groups. D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors
Imidaprilat
Imidaprilat, is the active metabolite of Imidapril. Imidapril is a prodrug used to treat hypertension, chronic congestive heart failure (CHF), acute myocardial infarction (AMI), and diabetic nephropathy (PMID: 17547476,18192036,12177688, 17094051). Imidapril belongs to a class of long-acting, non-sulfhydryl angiotensin-converting enzyme (ACE) inhibitors (PMID: 8851752, 12177688). Imidaprilat competitively binds and inhibits the catalytic activity of ACE, which results in a reduction of peripheral resistance and a reduction in systemic blood pressure (BP) (PMID: 17547476). Imidaprilat is only found in individuals that have used or taken imidapril. D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor
Reduced haloperidol
Reduced haloperidol is a metabolite of haloperidol. Haloperidol is a typical antipsychotic. It is in the butyrophenone class of antipsychotic medications and has pharmacological effects similar to the phenothiazines. Haloperidol is an older antipsychotic used in the treatment of schizophrenia and acute psychotic states and delirium. (Wikipedia)
7-[(3S,4S)-3-(Benzenesulfonamido)-2-bicyclo[2.2.1]heptanyl]hept-5-enoic acid
C20H27NO4S (377.1660702000001)
3-(2-(N-(1-Carboxy-3-phenylpropyl)amino)propionyl)-1-methyl-2-oxoimidazolidine-4-carboxylic acid
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors
5-Fluoro-adb, (+/-)-
Dioncophylline A
Etoperidone
C19H28ClN5O (377.19822680000004)
N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AB - Selective serotonin reuptake inhibitors C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent
(5alpha,17beta)-17-Benzoyl-4-azaandrost-1-en-3-one
Quilostigmine
Sulfinalol
C20H27NO4S (377.1660702000001)
Talarozole
C21H23N5S (377.16740780000003)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1740 - Aromatase Inhibitor D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist
(3E,6Z)-3-Benzylidene-6-[[4-[2-(dimethylamino)ethoxy]phenyl]methylidene]piperazine-2,5-dione
4-(1-phenylethyl)-n-[4-(1-phenylethyl)phenyl]aniline
(7E,9aS,11S,13S,13aS)-2,3,4,5,6,8,9,9a,10,11,12,13-dodecahydro-4,11-dimethyl-8-oxo-1H-indeno[1,7a-c]azonine-11,13-diyl diacetate|N-methyllycoposerramine-T
6-methoxy-11,12,13,14,14a,15-hexahydro-9H-benzo[h][1,3]dioxolo[4,5:4,5]benzo[1,2-f]pyrido[1,2-b]isoquinolin-12-ol|Cryptopleuridin|Cryptopleuridine
C23H23NO4 (377.16269980000004)
1,3-dihydroxy-10-methyl-2,4-bis(3-methylbut-2-enyl)-9(10H)-acridinone|N-methylatalaphylline
20-ethyl-1alpha,6beta,8-trihydroxy-4-methyl-heteratisan-14-one|Hetereophyllidin|O1-demethyl-heteratisine
6,7-(4,5,5-Trimethoxybiphenyl-2,2-diyl)-1,2,3,5,8,8a-hexahydro-8a-methylindolizine
Ala Cys Gly Lys
Ala Cys Lys Gly
Ala Gly Cys Lys
Ala Gly Lys Cys
Ala Lys Cys Gly
Ala Lys Gly Cys
Ala Asn Ser Ser
Ala Ser Asn Ser
Ala Ser Ser Asn
Cys Ala Gly Lys
Cys Ala Lys Gly
Cys Gly Ala Lys
Cys Gly Lys Ala
Cys Lys Ala Gly
Cys Lys Gly Ala
Gly Ala Cys Lys
Gly Ala Lys Cys
Gly Cys Ala Lys
Gly Cys Lys Ala
Gly Lys Ala Cys
Gly Lys Cys Ala
Gly Lys Ser Ser
Gly Asn Ser Thr
Gly Asn Thr Ser
Gly Gln Ser Ser
Gly Ser Lys Ser
Gly Ser Asn Thr
Gly Ser Gln Ser
Gly Ser Ser Lys
Gly Ser Ser Gln
Gly Ser Thr Asn
Gly Thr Asn Ser
Gly Thr Ser Asn
Lys Ala Cys Gly
Lys Ala Gly Cys
Lys Cys Ala Gly
Lys Cys Gly Ala
Lys Gly Ala Cys
Lys Gly Cys Ala
Lys Gly Ser Ser
Lys Ser Gly Ser
Lys Ser Ser Gly
Asn Ala Ser Ser
Asn Gly Ser Thr
Asn Gly Thr Ser
Asn Ser Ala Ser
Asn Ser Gly Thr
Asn Ser Ser Ala
Asn Ser Thr Gly
Asn Thr Gly Ser
Asn Thr Ser Gly
Gln Gly Ser Ser
Gln Ser Gly Ser
Gln Ser Ser Gly
Ser Gly Lys Ser
Ser Gly Ser Lys
Ser Lys Gly Ser
Ser Lys Ser Gly
Ser Ser Gly Lys
Ser Ser Lys Gly
Imidaprilat
A member of the class of imidazolidines that is imidapril in which the ethyl ester group has been hydrolysed to the corresponding acid group. It is the active metabolite of imidapril used to treat hypertension. D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor
1-Benzyl-4-(5,6-dimethoxy-1-oxoindan-2-ylindenemethyl)piperidine
[4-(3-Methoxyphenyl)-1-piperazinyl](5-methyl-3-phenyl-1,2-oxazol- 4-yl)methanone
1,3,3-trimethyl-2-[(methyl-2-naphthylhydrazono)methyl]-3H-indolium chloride
C23H24ClN3 (377.16586540000003)
3-AMINO-3-(3,4-DIBENZYLOXY-PHENYL)-PROPIONIC ACID
C23H23NO4 (377.16269980000004)
3-(4-Methoxybenzyloxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridinehydrochloride
C19H25BClNO4 (377.1565070000001)
Urea, N-cyclopropyl-N-[(1,2-dihydro-6-methyl-2-oxo-3-quinolinyl)methyl]-N-(2-methoxyphenyl)- (9CI)
Tetrabutylammonium chlorochromate
C16H36ClCrNO3 (377.1788676000001)
3-Dibenzylamino-2-fluoropropionic acid, benzyl ester
dibutyl [[(diethylamino)thioxomethyl]thio]succinate
Methanone, [4-(4-methoxyphenyl)-1-piperazinyl](5-methyl-3-phenyl-4-isoxazolyl)-
Sulfinalol
C20H27NO4S (377.1660702000001)
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist
Propafenone hydrochloride
C21H28ClNO3 (377.17576080000003)
D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers > D061567 - Voltage-Gated Sodium Channel Blockers C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
tert-Butyl 5-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate
C19H25BClNO4 (377.1565070000001)
tert-Butyl 7-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate
C19H25BClNO4 (377.1565070000001)
GR 46611
GR-46611 is a 5-HT1D receptor agonist. GR-46611 can be used in the research of bladder hyperactivity, leukemia[1][3].
Setiptiline maleate
C23H23NO4 (377.16269980000004)
Setiptiline maleate (MO-8282 maleate) is a serotonin receptor antagonist. Setiptiline maleate is a tetracyclic antidepressant (TeCA) which acts as a noradrenergic and specific serotonergic antidepressant (NaSSA). Setiptiline maleate acts as a norepinephrine reuptake inhibitor, α2-adrenergic receptor antagonist, and serotonin receptor antagonist, likely at the 5-HT2A, 5-HT2C, and/or 5-HT3 subtypes, as well as an H1 receptor inverse agonist/antihistamine[1][2][3][4].
Domitroban
C20H27NO4S (377.1660702000001)
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D011448 - Prostaglandin Antagonists C78275 - Agent Affecting Blood or Body Fluid > C29750 - Thrombolytic Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors
1-O-tert-butyl 4-O-ethyl 4-[(4-methoxyphenyl)methyl]piperidine-1,4-dicarboxylate
CHLORHEXIDENE DIACETATE IMPURITY A
C16H24ClN9 (377.18430939999996)
tert-Butyl 6-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate
C19H25BClNO4 (377.1565070000001)
2-[(1-Benzyl-4-Piperidinyl)Methylene]-5,6-Dimethoxy-1-Indanone
POLY(4-VINYLPYRIDINIUM POLY(HYDROGEN
C21H26F3N3 (377.20787120000006)
N-Fmoc-2-amino-2-(2-propenyl)-4-Pentenoic acid
C23H23NO4 (377.16269980000004)
(3R,4S)-tert-Butyl 2-oxo-4-phenyl-3-(triethylsilyloxy)azetidine-1-carboxylate
Morazone
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
1-(6-((3-Cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[D]azepin-7-YL)oxy)pyridin-3-YL)pyrrolidin-2-one
Carmegliptin
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98086 - Dipeptidyl Peptidase-4 Inhibitor C471 - Enzyme Inhibitor > C783 - Protease Inhibitor
4-Hydroxy-7-isopropyl-6-oxo-n-(3-(1-piperidinyl)propyl)-6,7-dihydrothieno(2,3-b)pyridine-5-carboxamide
3-((4-(2-(Dimethylamino)ethoxy)phenyl)methylene)-6-(phenylmethylene)-2,5-piperazinedione
1-[3-(4-Morpholinyl)propylamino]-3-propan-2-yl-4-pyrido[1,2-a]benzimidazolecarbonitrile
2-[2-Amino-5-(4-methoxyphenyl)-6-methylpyrimidin-4-yl]-5-[(2-methylprop-2-en-1-yl)oxy]phenol
5-benzoyl-6-methyl-4-[4-(4-morpholinyl)phenyl]-3,4-dihydro-1H-pyrimidin-2-one
Diethylaminoethyl diphenylhydroxypropionate hydrochloride
C21H28ClNO3 (377.17576080000003)
L-Phenylalanyl-L-isoleucyl-L-valine
C20H31N3O4 (377.23144460000003)
[(2S,3R,4E,14Z)-2-amino-3-hydroxyoctadeca-4,14-dienyl] dihydrogen phosphate
C18H36NO5P (377.23309760000006)
(3s)-1-(1,3-Benzodioxol-5-Ylmethyl)-3-[4-(1h-Imidazol-1-Yl)phenoxy]piperidine
2-{3-[4-(4-Fluorophenyl)-3,6-dihydro-1(2H)-pyridinyl]propyl}-8-methyl-4(3H)-quinazolinone
2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide
Talarozole
C21H23N5S (377.16740780000003)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1740 - Aromatase Inhibitor D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist
N-[2-(1H-indol-3-yl)ethyl]-1-methyl-4-(morpholin-4-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-amine
2-[2-(1-Carboxyethylamino)ethylamino]-6-[(3-carboxy-3-hydroxypropanoyl)amino]hexanoic acid
Protuboxepin A
An organic heterotricyclic compound that is 10,11-dihydro-6H-oxepino[2,3-d]pyrazino[1,2-a]pyrimidine-6,9(8H)-dione substituted by a benzyl group at position 8 and a butan-2-yl group at position 11. It has been isolated from Aspergillus species.
Dioncophylline A
An isoquinoline alkaloid that is the biaryl resulting from substitution of the hydrogen at the 7-position of (1R,3R)-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-8-ol by a 4,5-dimethoxy-2-methylnaphthalen-1-yl group. It is a naphthylisoquinoline alkaloid isolated from the roots and stem barks of Triphyophyllum peltatum and exhibits antifungal, antimalarial, antineoplastic and molluscicidal activites.
7-[(4-Methyl-1-piperazinyl)methyl]-5-(phenylmethoxymethyl)-8-quinolinol
3-methoxy-N-[4-methyl-2-(4-morpholinyl)-6-quinolinyl]benzamide
N-(2-furanylmethyl)-3-(2,4,8,10-tetramethyl-3-pyrido[2,3]pyrazolo[2,4-a]pyrimidinyl)propanamide
3-[(2-fluorophenyl)methyl]-5-propyl-N-(pyridin-4-ylmethyl)-7-triazolo[4,5-d]pyrimidinamine
12-(Phosphonooxy)octadecanoate(3-)
C18H34O6P-3 (377.20928940000005)
1-(2-Methoxyphenyl)-4-{[5-(4-methylphenyl)-3-isoxazolyl]carbonyl}piperazine
1-(3-Chlorophenyl)-3-(9-cyclopentyl-9-azabicyclo[3.3.1]nonan-3-yl)thiourea
C20H28ClN3S (377.1692358000001)
5-ethyl-3-[(2-fluorophenyl)methyl]-N-[2-(2-pyridinyl)ethyl]-7-triazolo[4,5-d]pyrimidinamine
1-(3,4-dihydro-1H-isoquinolin-2-yl)-2-[(2-propyl-4-quinazolinyl)thio]ethanone
C22H23N3OS (377.15617480000003)
N-methyl-N-(3-pyridinylmethyl)-5-(5,6,7,8-tetrahydronaphthalen-2-yloxymethyl)-3-isoxazolecarboxamide
N-[1-(3,4-dimethylphenyl)-4,5,6,7-tetrahydroindazol-4-yl]-2-(3,5-dimethyl-1-pyrazolyl)acetamide
(8E,10Z,14E,16Z,18E)-7,13,20-trihydroxydocosa-8,10,14,16,18-pentaenoate
C22H33O5- (377.23278680000004)
(8Z,10E,14E,16Z,19Z)-7,12,13-trihydroxydocosa-8,10,14,16,19-pentaenoate
C22H33O5- (377.23278680000004)
N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C20H31N3O4 (377.23144460000003)
N-[[(2S,3R,4R)-3-[4-(1-cyclopentenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-methyl-2-pyridinecarboxamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C20H31N3O4 (377.23144460000003)
2-[(3R,6aS,8R,10aS)-3-hydroxy-1-(pyridine-2-carbonyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
2-[(3S,6aR,8S,10aR)-3-hydroxy-1-(pyridine-4-carbonyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N,N-dimethylacetamide
2-[(3S,6aS,8S,10aS)-3-hydroxy-1-(pyridine-4-carbonyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N,N-dimethylacetamide
2-[(3R,6aS,8S,10aS)-3-hydroxy-1-(pyridine-2-carbonyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
2-[(3S,6aR,8R,10aR)-3-hydroxy-1-[oxo(2-pyridinyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
2-[(3S,6aS,8R,10aS)-3-hydroxy-1-(pyridine-2-carbonyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
2-[(3R,6aR,8R,10aR)-3-hydroxy-1-[oxo(2-pyridinyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
2-[(3R,6aR,8S,10aR)-3-hydroxy-1-(pyridine-2-carbonyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
2-[(3R,6aS,8R,10aS)-3-hydroxy-1-(pyridine-4-carbonyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N,N-dimethylacetamide
2-[(3S,6aS,8R,10aS)-3-hydroxy-1-[oxo(pyridin-4-yl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N,N-dimethylacetamide
2-[(3R,6aS,8S,10aS)-3-hydroxy-1-[oxo(pyridin-4-yl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N,N-dimethylacetamide
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C20H31N3O4 (377.23144460000003)
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C20H31N3O4 (377.23144460000003)
N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C20H31N3O4 (377.23144460000003)
N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C20H31N3O4 (377.23144460000003)
2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[oxo(propylamino)methyl]amino]-2-oxanyl]-N-(2-phenylethyl)acetamide
C20H31N3O4 (377.23144460000003)
2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[oxo(propylamino)methyl]amino]-2-oxanyl]-N-(2-phenylethyl)acetamide
C20H31N3O4 (377.23144460000003)
2-[(3S,6aR,8S,10aR)-3-hydroxy-1-[oxo(2-pyridinyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
2-[(3S,6aR,8R,10aR)-3-hydroxy-1-[oxo(pyridin-4-yl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N,N-dimethylacetamide
2-[(3R,6aR,8S,10aR)-3-hydroxy-1-[oxo(pyridin-4-yl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N,N-dimethylacetamide
1-[(3aR,4R,9bS)-4-(hydroxymethyl)-5-methyl-8-[(E)-prop-1-enyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-2-pyridin-3-ylethanone
(1R,5S)-N-(1,3-benzodioxol-5-yl)-7-[4-[(E)-prop-1-enyl]phenyl]-3,6-diazabicyclo[3.1.1]heptane-6-carboxamide
2-cyclopropyl-1-[(2S,3R)-2-(hydroxymethyl)-3-phenyl-6-(3-pyridinylmethyl)-1,6-diazaspiro[3.3]heptan-1-yl]ethanone
(6R,7R,8S)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-4-(pyridine-4-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7S,8R)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-4-(pyridine-4-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8R)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-4-(pyridine-4-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one
cyclobutyl-[(2S,3R)-2-(hydroxymethyl)-3-phenyl-1-(3-pyridinylmethyl)-1,6-diazaspiro[3.3]heptan-6-yl]methanone
cyclobutyl-[(2R,3R)-2-(hydroxymethyl)-3-phenyl-1-(3-pyridinylmethyl)-1,6-diazaspiro[3.3]heptan-6-yl]methanone
2-cyclopropyl-1-[(2R,3R)-2-(hydroxymethyl)-3-phenyl-1-(2-pyridinylmethyl)-1,6-diazaspiro[3.3]heptan-6-yl]ethanone
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C20H31N3O4 (377.23144460000003)
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C20H31N3O4 (377.23144460000003)
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C20H31N3O4 (377.23144460000003)
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C20H31N3O4 (377.23144460000003)
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C20H31N3O4 (377.23144460000003)
N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C20H31N3O4 (377.23144460000003)
N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C20H31N3O4 (377.23144460000003)
N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C20H31N3O4 (377.23144460000003)
N-[(5R,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C20H31N3O4 (377.23144460000003)
N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C20H31N3O4 (377.23144460000003)
2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[oxo(propylamino)methyl]amino]-2-oxanyl]-N-(2-phenylethyl)acetamide
C20H31N3O4 (377.23144460000003)
2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[oxo(propylamino)methyl]amino]-2-oxanyl]-N-(2-phenylethyl)acetamide
C20H31N3O4 (377.23144460000003)
2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[oxo(propylamino)methyl]amino]-2-oxanyl]-N-(2-phenylethyl)acetamide
C20H31N3O4 (377.23144460000003)
2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[oxo(propylamino)methyl]amino]-2-oxanyl]-N-(2-phenylethyl)acetamide
C20H31N3O4 (377.23144460000003)
2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[oxo(propylamino)methyl]amino]-2-oxanyl]-N-(2-phenylethyl)acetamide
C20H31N3O4 (377.23144460000003)
2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[oxo(propylamino)methyl]amino]-2-oxanyl]-N-(2-phenylethyl)acetamide
C20H31N3O4 (377.23144460000003)
2-[(3S,6aS,8S,10aS)-3-hydroxy-1-[oxo(2-pyridinyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
2-[(3R,6aR,8R,10aR)-3-hydroxy-1-[oxo(pyridin-4-yl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N,N-dimethylacetamide
2-[(3R,6aR,8S,10aR)-3-hydroxy-1-[oxo(3-pyridinyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
1-[(3aR,4S,9bS)-4-(hydroxymethyl)-5-methyl-8-[(E)-prop-1-enyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-2-pyridin-3-ylethanone
1-[(3aS,4R,9bR)-4-(hydroxymethyl)-5-methyl-8-[(E)-prop-1-enyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-2-pyridin-3-ylethanone
1-[(3aS,4S,9bR)-4-(hydroxymethyl)-5-methyl-8-[(E)-prop-1-enyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-2-pyridin-3-ylethanone
2-[[(1S,5R)-7-[4-(2-methoxyphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]methyl]thiazole
C22H23N3OS (377.15617480000003)
(1S,5R)-N-(1,3-benzodioxol-5-yl)-7-[4-[(E)-prop-1-enyl]phenyl]-3,6-diazabicyclo[3.1.1]heptane-3-carboxamide
(6R,7R,8R)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-4-(pyridine-4-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7S,8S)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-4-(pyridine-4-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8S)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-4-(pyridine-4-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7R,8R)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-4-(pyridine-4-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one
2-cyclopropyl-1-[(2S,3R)-2-(hydroxymethyl)-3-phenyl-1-(2-pyridinylmethyl)-1,6-diazaspiro[3.3]heptan-6-yl]ethanone
2-cyclopropyl-1-[(2S,3S)-2-(hydroxymethyl)-3-phenyl-1-(2-pyridinylmethyl)-1,6-diazaspiro[3.3]heptan-6-yl]ethanone
(9E,11E,14E,16Z,19Z)-7,8,13-trihydroxydocosa-9,11,14,16,19-pentaenoate
C22H33O5- (377.23278680000004)
(14E,19Z)-7,16,17-trihydroxydocosa-8,10,12,14,19-pentaenoate
C22H33O5- (377.23278680000004)
(7S,15E,17S,19Z)-7,8,17-trihydroxydocosa-9,11,13,15,19-pentaenoate
C22H33O5- (377.23278680000004)
2-methyl-4-(1-methyl-4-pyrazolyl)-N-(5-methyl-2-pyridinyl)-5-oxo-4a,6,7,8-tetrahydro-4H-quinoline-3-carboxamide
ethyl 2-[(4E)-4-[[4-(dimethylamino)phenyl]methylidene]-5-oxo-1-phenylpyrazol-3-yl]acetate
2-(6-methoxypyridin-2-yl)-4-pyrrolidin-1-yl-1-[[(2R)-pyrrolidin-2-yl]methyl]benzimidazole
(8aR)-2-(1-benzothiophen-2-ylmethyl)-7-benzyl-5,6,8,8a-tetrahydro-1H-imidazo[1,5-a]pyrazin-3-one
C22H23N3OS (377.15617480000003)
N-Isobutyl 9-(para-phenoxyphenyl)-2,4-nonadienamide
ETOPERIDONE
C19H28ClN5O (377.19822680000004)
N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AB - Selective serotonin reuptake inhibitors C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent
7,16,17-trihydroxy-(14E,19Z)-docosa-8,10,12,14,19-pentaenoate
A docosanoid anion that is the conjugate base of 7,16,17-trihydroxy-(14E,19Z)-docosa-8,10,12,14,19-pentaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.
sphingadienine-1-phosphate
C18H36NO5P (377.23309760000006)
A sphingoid 1-phosphate that is sphingadienine substituted by a phospho group at position 1.
(7S,8,17S)-trihydroxy-(15E,19Z)-docosa-9,11,13,15,19-pentaenoate
A docosanoid anion that is the conjugate base of (7S,8,17S)-trihydroxy-(15E,19Z)-docosa-9,11,13,15,19-pentaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.
resolvin T1(1-)
A docosanoid anion that is the conjugate base of resolvin T1, obtained by deprotonation of the carboxy group; major species at pH 7.3.
resolvin T2(1-)
A docosanoid anion that is the conjugate base of resolvin T2, obtained by deprotonation of the carboxy group; major species at pH 7.3.
resolvin T3(1-)
A docosanoid anion that is the conjugate base of resolvin T3, obtained by deprotonation of the carboxy group; major species at pH 7.3.
CJ033466
C19H28ClN5O (377.19822680000004)
CJ033466 is a novel and selective 5-HT4 receptor partial agonist with an EC50 of 9 nM and has gastroprokinetic effect[1].
Co 101244 (hydrochloride)
C21H28ClNO3 (377.17576080000003)
Co 101244 (PD 174494) hydrochloride is a NR2B-containing NMDA receptor antagonist[1].
MCU-i4
MCU-i4 blocks the IP3-dependent mitochondrial Ca2+-uptake, maintaining the gatekeeping role of their target[1][2].
1-hydroxy-2-methyl-3-(3,7,11-trimethyldodeca-2,4,6,10-tetraen-1-yl)quinolin-4-one
1-hydroxy-10-methyl-4,4-bis(3-methylbut-2-en-1-yl)acridine-3,9-dione
(23r)-12,13-dimethoxy-5,7-dioxa-19-azahexacyclo[15.7.0.0²,¹⁰.0⁴,⁸.0¹¹,¹⁶.0¹⁹,²³]tetracosa-1(17),2(10),3,8,11(16),12,14-heptaene
C23H23NO4 (377.16269980000004)
(2e)-n-[(1s,2s,4's,5'r,6s)-5'-hydroxy-3-oxo-7-oxaspiro[bicyclo[4.1.0]heptane-2,2'-oxolan]-4-en-4'-yl]dodec-2-enimidic acid
(1s,4r)-4-benzyl-3,10-dihydroxy-1-(sec-butyl)-1h,4h-pyrazino[2,1-b]quinazolin-6-one
(1r,4e,6s,7r,17s)-4-ethylidene-6,7-dimethyl-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-7-yl acetate
C20H27NO6 (377.18382820000005)
n-{3-[(2e)-n-{4-[(hydroxymethylidene)amino]butyl}-3-phenylprop-2-enamido]propyl}methylsulfanylcarboximidic acid
n-[2-(4-{[(2e)-3,7-dimethylocta-2,6-dien-1-yl]oxy}phenyl)ethyl]benzenecarboximidic acid
(3r)-7-(4,5-dimethoxy-2-methylnaphthalen-1-yl)-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-8-ol
8-o-methyl-1-epi-dioncophylline b
{"Ingredient_id": "HBIN013860","Ingredient_name": "8-o-methyl-1-epi-dioncophylline b","Alias": "NA","Ingredient_formula": "C24H27NO3","Ingredient_Smile": "CC1CC2=C(C(N1)C)C(=C(C=C2)C3=C(C4=C(C=C3)C=C(C=C4OC)C)O)OC","Ingredient_weight": "377.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14389","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10571649","DrugBank_id": "NA"}
(1s,2r,3s,6r,9s,10r,11r,14r,17s,18r,19s)-12-ethyl-9,17,19-trihydroxy-14-methyl-5-oxa-12-azahexacyclo[8.7.2.1²,⁶.0¹,¹¹.0³,⁹.0¹⁴,¹⁸]icosan-4-one
(1s,2r,5s,11s,14s)-11-hydroxy-1,2-dimethyl-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-9,16(24),17,19,21-pentaen-8-one
11-hydroxy-1,2-dimethyl-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-9,16(24),17,19,21-pentaen-8-one
(1r,1'r,5s,6'r)-5-hydroxy-2',3',4-trimethoxy-10'-methyl-10'-azaspiro[cyclohexane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione
C20H27NO6 (377.18382820000005)
(1s,12r,13r)-5-methoxy-12-(2-methoxyphenyl)-6-methyl-16-oxa-7-azatetracyclo[11.2.1.0²,¹¹.0³,⁸]hexadeca-2,5,8,10-tetraen-4-one
C23H23NO4 (377.16269980000004)
8-methoxy-2-[(1s,3r)-8-methoxy-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-7-yl]-6-methylnaphthalen-1-ol
n-[(1s,2s,4's,5'r,6s)-5'-hydroxy-3-oxo-7-oxaspiro[bicyclo[4.1.0]heptane-2,2'-oxolan]-4-en-4'-yl]dodec-2-enimidic acid
5,10-dihydroxy-2,2-dimethyl-12-(3-methylbut-2-en-1-yl)-11h-1-oxa-11-azatetracen-6-one
C23H23NO4 (377.16269980000004)
(9s,13r)-13-[(2r,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,9,13-trihydroxytridecan-4-one
C18H35NO7 (377.24134000000004)
(21s)-5,10,11-trimethoxy-16-azapentacyclo[12.8.0.0²,⁷.0⁸,¹³.0¹⁶,²¹]docosa-1(14),2(7),3,5,8(13),9,11-heptaene
8-methoxy-4-[(1r,3r)-8-methoxy-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-7-yl]-6-methylnaphthalen-1-ol
(8r,12s)-6-hydroxy-8-phenyl-1,5,9-triazatricyclo[10.7.1.0¹³,¹⁸]icosa-5,13,15,17-tetraen-19-one
13-[3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,9,13-trihydroxytridecan-4-one
C18H35NO7 (377.24134000000004)
8-methoxy-4-(8-methoxy-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-7-yl)-6-methylnaphthalen-1-ol
(21r,24s)-13-methoxy-5,7-dioxa-19-azahexacyclo[15.8.0.0²,¹⁰.0⁴,⁸.0¹¹,¹⁶.0¹⁹,²⁴]pentacosa-1(17),2(10),3,8,11(16),12,14-heptaen-21-ol
C23H23NO4 (377.16269980000004)
2-(4,8-dimethylnona-1,3,7-trien-1-yl)-2,5-dimethyl-3h,4h-pyrano[3,2-c]quinolin-6-ium-6-olate
(1s,2s,8s,9s)-9-{[2-(1h-indol-3-yl)ethyl]amino}-14-oxa-7-azatetracyclo[6.6.1.0¹,¹¹.0²,⁷]pentadec-11-en-13-one
4-ethylidene-6,7-dimethyl-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-7-yl acetate
C20H27NO6 (377.18382820000005)
3-{2,4-dihydroxy-5-[(2e,4e)-n-(2-hydroxyethyl)-7-methylocta-2,4-dienamido]phenyl}propanoic acid
C20H27NO6 (377.18382820000005)
methyl (3s,4s,4ar,13bs)-3-hydroxy-4,13b-dimethyl-1h,2h,3h,4ah,5h,6h,8h-naphtho[2,1-b]carbazole-4-carboxylate
4,5,10-trimethoxy-16-azapentacyclo[12.8.0.0²,⁷.0⁸,¹³.0¹⁶,²¹]docosa-1(14),2(7),3,5,8(13),9,11-heptaene
(1r,13s,14s,16r,19s)-10-carbamoyl-14-ethyl-9-oxo-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6,10,12(21)-pentaen-16-ium-16-olate
8-(3,7-dimethylocta-2,6-dien-1-yl)-7-methoxy-3-methyl-9h-carbazole-1,4-dione
12,13-dimethoxy-5,7-dioxa-19-azahexacyclo[15.7.0.0²,¹⁰.0⁴,⁸.0¹¹,¹⁶.0¹⁹,²³]tetracosa-1(17),2(10),3,8,11(16),12,14-heptaene
C23H23NO4 (377.16269980000004)
8-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-7-methoxy-3-methyl-9h-carbazole-1,4-dione
13-methoxy-5,7-dioxa-19-azahexacyclo[15.8.0.0²,¹⁰.0⁴,⁸.0¹¹,¹⁶.0¹⁹,²⁴]pentacosa-1(17),2(10),3,8,11(16),12,14-heptaen-21-ol
C23H23NO4 (377.16269980000004)
(1s,8s,10s,11r,12s,13s)-3,4,12-trimethoxy-17-methyl-18-oxa-17-azapentacyclo[8.4.3.1⁸,¹¹.0¹,¹⁰.0²,⁷]octadeca-2,4,6-triene-11,13-diol
C20H27NO6 (377.18382820000005)
(1r,3s)-7-(4,5-dimethoxy-2-methylnaphthalen-1-yl)-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-8-ol
(7s,12r)-9-hydroxy-7-phenyl-1,6,10-triazatricyclo[10.7.1.0¹³,¹⁸]icosa-9,13,15,17-tetraen-19-one
(1r,13s,14s,19s)-10-carbamoyl-14-ethyl-9-oxo-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6,10,12(21)-pentaen-16-ium-16-olate
(1r,4e,6r,7r,17r)-4-ethylidene-6,7-dimethyl-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-7-yl acetate
C20H27NO6 (377.18382820000005)
12-ethyl-9,17,19-trihydroxy-14-methyl-5-oxa-12-azahexacyclo[8.7.2.1²,⁶.0¹,¹¹.0³,⁹.0¹⁴,¹⁸]icosan-4-one
methyl (1s,3r,4s,11s,13s,14e)-3,4-dimethoxy-14-(2-methoxy-2-oxoethylidene)-9-azatetracyclo[7.5.0.0¹,⁶.0¹¹,¹³]tetradec-5-ene-13-carboxylate
C20H27NO6 (377.18382820000005)
8-(3,7-dimethylocta-2,6-dien-1-yl)-2-hydroxy-7-methoxy-9h-carbazole-3-carbaldehyde
(4s,7r)-7-benzyl-6-hydroxy-4-(sec-butyl)-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one
2-benzyl-7-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-phenylprop-2-enoate
3-[(3e)-4,8-dimethylnona-3,7-dien-1-yl]-3,5-dimethylpyrano[2,3-c]quinolin-6-ium-6-olate
2-[2,6-dihydroxy-3,8-dimethylidene-4-(pyrrolidine-2-carbonyloxy)-octahydroazulen-5-yl]prop-2-enoic acid
C20H27NO6 (377.18382820000005)
4-benzyl-3,10-dihydroxy-1-(sec-butyl)-1h,4h-pyrazino[2,1-b]quinazolin-6-one
8-methoxy-5-(8-methoxy-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-7-yl)-6-methylnaphthalen-1-ol
3,4,12-trimethoxy-17-methyl-18-oxa-17-azapentacyclo[8.4.3.1⁸,¹¹.0¹,¹⁰.0²,⁷]octadeca-2,4,6-triene-11,13-diol
C20H27NO6 (377.18382820000005)
(1s,2r,5s,6r,10r,13s)-6,10-dihydroxy-1,2-dimethyl-22-azahexacyclo[11.10.0.0²,¹⁰.0⁵,⁹.0¹⁵,²³.0¹⁶,²¹]tricosa-8,15(23),16,18,20-pentaen-7-one
6-hydroxy-8-phenyl-1,5,9-triazatricyclo[10.7.1.0¹³,¹⁸]icosa-5,13,15,17-tetraen-19-one
8-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-2-hydroxy-7-methoxy-9h-carbazole-3-carbaldehyde
9-{[2-(1h-indol-3-yl)ethyl]amino}-14-oxa-7-azatetracyclo[6.6.1.0¹,¹¹.0²,⁷]pentadec-11-en-13-one
2-[(3e)-4,8-dimethylnona-3,7-dien-1-yl]-2,5-dimethylpyrano[3,2-c]quinolin-6-ium-6-olate
n-{5'-hydroxy-3-oxo-7-oxaspiro[bicyclo[4.1.0]heptane-2,2'-oxolan]-4-en-4'-yl}dodec-2-enimidic acid
2-(4,8-dimethylnona-3,7-dien-1-yl)-2,5-dimethylpyrano[3,2-c]quinolin-6-ium-6-olate
(4r,7s)-7-benzyl-6-hydroxy-4-(sec-butyl)-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one
(1r,3s,5r,6s)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoate
C20H27NO6 (377.18382820000005)
8-methoxy-2-(8-methoxy-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-7-yl)-6-methylnaphthalen-1-ol
5-hydroxy-2',3',4-trimethoxy-10'-methyl-10'-azaspiro[cyclohexane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione
C20H27NO6 (377.18382820000005)
9-hydroxy-7-phenyl-1,6,10-triazatricyclo[10.7.1.0¹³,¹⁸]icosa-9,13,15,17-tetraen-19-one
2-[(1e,3e)-4,8-dimethylnona-1,3,7-trien-1-yl]-2,5-dimethyl-3h,4h-pyrano[3,2-c]quinolin-6-ium-6-olate
8-methoxy-5-[(1r,3r)-8-methoxy-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-7-yl]-6-methylnaphthalen-1-ol
(1r,2r,3s,5r,7s)-2-benzyl-7-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2e)-3-phenylprop-2-enoate
3-(4,8-dimethylnona-3,7-dien-1-yl)-3,5-dimethylpyrano[2,3-c]quinolin-6-ium-6-olate
n-[3-(n-{4-[(hydroxymethylidene)amino]butyl}-3-phenylprop-2-enamido)propyl]methylsulfanylcarboximidic acid
6,11-dihydroxy-2,2-dimethyl-12-(3-methylbut-2-en-1-yl)-5h-1-oxa-5-azatetraphen-10-one
C23H23NO4 (377.16269980000004)
7-benzyl-6-hydroxy-4-(sec-butyl)-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one
(1s,8s,10s,11r,12s,13s)-4,11,12-trimethoxy-17-methyl-18-oxa-17-azapentacyclo[8.4.3.1⁸,¹¹.0¹,¹⁰.0²,⁷]octadeca-2,4,6-triene-3,13-diol
C20H27NO6 (377.18382820000005)
(2s)-6-[(3-carboxy-1,3-dihydroxypropylidene)amino]-2-({2-[(1-carboxyethyl)amino]ethyl}amino)hexanoic acid
1,3-dihydroxy-10-methyl-2,4-bis(3-methylbut-2-en-1-yl)acridin-9-one
1-hydroxy-2-methyl-3-[(2e,4e,6e)-3,7,11-trimethyldodeca-2,4,6,10-tetraen-1-yl]quinolin-4-one
6-[(3-carboxy-1,3-dihydroxypropylidene)amino]-2-({2-[(1-carboxyethyl)amino]ethyl}amino)hexanoic acid
2-[(2s,3ar,4r,5r,6s,8ar)-2,6-dihydroxy-3,8-dimethylidene-4-[(2s)-pyrrolidine-2-carbonyloxy]-octahydroazulen-5-yl]prop-2-enoic acid
C20H27NO6 (377.18382820000005)
3-{2,4-dihydroxy-5-[n-(2-hydroxyethyl)-7-methylocta-2,4-dienamido]phenyl}propanoic acid
C20H27NO6 (377.18382820000005)
methyl 3,4-dimethoxy-14-(2-methoxy-2-oxoethylidene)-9-azatetracyclo[7.5.0.0¹,⁶.0¹¹,¹³]tetradec-5-ene-13-carboxylate
C20H27NO6 (377.18382820000005)